« Previous
Next »
The Journal of Pediatrics
Volume 152, Issue 4
, Pages 481-488
, April 2008
Health Plan Notification and Feedback to Providers is Associated with Increased Filling of Preventer Medications for Children with Asthma Enrolled in Medicaid
References
- . Comparison of perinatal outcomes among TennCare managed care organizations. Pediatrics. 1999;104(3 Pt 1):525–529
- . Longitudinal trends in race/ethnic disparities in leading health indicators from adolescence to young adulthood. Arch Pediatr Adolesc Med. 2006;160:74–81
- . Measuring progress towards reducing health inequalities. Bull World Health Organ. 2005;83:162
- . Historical overview of children’s health care coverage. Future Child. 2003;13:31–53
- . Three years of state fiscal struggles: how did Medicaid and SCHIP fare?. Health Aff. 2005;(Millwood); Suppl Web Exclusives:W5-385-98.
- . Medicaid cost containment and access to prescription drugs. Health Aff. 2005;24:780–789(Millwood)
- . Evaluating medicaid managed care programs for children. Ambul Pediatr. 2001;1:112–116
- . Medicaid managed care (Center for Medicare and Medicaid Services). Accessed Dec 13 http://www.cms.hhs.gov/MedicaidManagCare/2006;
- . Medicaid managed care and high quality (Can we have both?). JAMA. 1997;278:1617–1621
- . Medicaid managed care: lessons from five states. Health Aff (Millwood). 1996;15:153–166
- . Growing an industry: how managed is TennCare’s managed care?. Health Aff. 2000;19:86–101(Millwood)
- . Medicaid and managed care. N Engl J Med. 1995;332:1727–1731
- . Gaps in enrollment from a Medicaid managed care program: effects on emergency department visits and hospitalizations for children with asthma. Med Care. 2005;43:718–725
- . Healthy Options enrollment (Washington State Department of Social and Health Services 2006). Accessed Dec 13 http://fortress.wa.gov/dshs/maa/HealthyOptions/2006;
- . Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837–849
- . Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA. 2003;290:1057–1061
- ICD-9-CM International classification of diseases, ninth revision, clinical modification. 6th ed. Washington, DC: US Department of Health and Human Services, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services; 2002;
- Current procedural terminology. 4th ed. Chicago: American Medical Association; 1999;revised
- . Highlights of the expert panel report 2: guidelines for the diagnosis and management of asthma. NIH Publication No. 97-4051A. Bethesda, MD: NIH; 1997;
- Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs. Ann Allergy Asthma Immunol. 2004;92:319–328
- . Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1173–1180
- . Assessing the relationship between quality of care and the characteristics of health care organizations. Med Care Res Rev. 2000;57(Suppl 2):116–135
- . Quality management practices in Medicaid managed care: a national survey of Medicaid and commercial health plans participating in the Medicaid program. JAMA. 1999;282:1769–1775
- Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med. 2001;155:501–507
- . Continuity of care for children in foster care. Pediatrics. 2003;111:e208–e213
- . Variability in asthma care and services for low-income populations among practice sites in managed Medicaid systems. Health Serv Res. 2003;38(6 Pt 1):1563–1578
- . Is there a best outcome measurement for patients with asthma?. Ann Allergy Asthma Immunol. 2006;97:432–439
- Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107:706–711
- Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care. 2004;42:465–471
Conflicts of Interest: Drs Ray and Arbogast report receiving grant support from Pfizer for work unrelated to the research reported in this manuscript.
Supported by the Agency for Healthcare Research and Quality (HS#13076) and the Agency for Healthcare Research and Quality, Centers for Education and Research on Therapeutics (HS#10384). The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review, or approval of the manuscript. The first draft was written by Dr Cooper.
PII: S0022-3476(07)00847-5
doi: 10.1016/j.jpeds.2007.08.046
© 2008 Mosby, Inc. All rights reserved.
« Previous
Next »
The Journal of Pediatrics
Volume 152, Issue 4
, Pages 481-488
, April 2008
